±Û ¼öÁ¤Çϱâ
±Û¾´ÀÌ
E-mail
Homepage
±ÛÁ¦¸ñ
±Û
How many more years do you have to go?
fluoxetine hcl 20 mg capsule treatment uae
Alirocumab is an investigational, fully-human monoclonal antibody that targets and blocks PCSK9. It is administered via subcutaneous injection. By inhibiting PCSK9, a determinant of circulating LDL-C levels in the blood, alirocumab has been shown in pre-clinical studies to increase the number of LDL receptors on hepatocytes, thereby lowering LDL-C.
ºñ¹Ð¹øÈ£
(¼öÁ¤°ú »èÁ¦½Ã ÇÊ¿ä!! )